Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
LPAR2 encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. Zusätzlich bieten wir Ihnen Lysophosphatidic Acid Receptor 2 Proteine (5) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 76 products:
Human Polyclonal LPAR2 Primary Antibody für IHC (p), WB - ABIN390085
Horak, Lee, Elkahloun, Boissan, Dumont, Maga, Arnaud-Dabernat, Palmieri, Stetler-Stevenson, Lacombe, Meltzer, Steeg: Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. in Cancer research 2007
Show all 4 Pubmed References
Human Polyclonal LPAR2 Primary Antibody für WB - ABIN265051
An, Goetzl, Lee: Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. in Journal of cellular biochemistry. Supplement 1999
Show all 4 Pubmed References
LPAR2 signaling is required for in vivo neural crest cell migration.
These results suggest that LPA (zeige APOA Antikörper) signaling via LPA2 may play an important role in the regulation of cellular functions in HT1080 (zeige CDC123 Antikörper) cells treated with cisplatin.
LPA2 mRNA levels were associated with poorer differentiation, and higher LPA6 levels were associated with microvascular invasion in HCC; both became a risk factor for recurrence after surgical treatment when combined with increased serum ATX levels
epithelial dysplasia was observed in founder mouse intestine, correlating LPA2 overexpression with epithelial dysplasia. The current study demonstrates that overexpression of LPA2 alone can lead to intestinal dysplasia.
LPA2 expression was associated with HIF-1alpha (zeige HIF1A Antikörper) expression and that a high level of LPA2 was associated with shorter overall survival and was an independent prognostic predictor for breast cancer in Chinese women.
LPAR2 mRNA is up-regulation in colorectal cancer.
Data show high expression levels of LPAR2 and LPAR1 (zeige LPAR1 Antikörper) in endometrial cancer tissue with positive correlations with FIGO stage suggesting them as potential biomarkers for endometrial cancer progression.
Suggest that LPA2 and LPA3 (zeige LPAR3 Antikörper) may function as a molecular switch and play opposing roles during megakaryopoiesis of K562 cells.
the RhoA (zeige RHOA Antikörper)-regulated formin (zeige FMN1 Antikörper) Dia1 (zeige CYB5R3 Antikörper) is involved in entosis downstream of LPAR2
Crystal structure of NHERF2 (zeige SLC9A3R2 Antikörper) PDZ1 domain complex with C-terminal LPA2 sequence. The PDZ1-LPA2 binding specificity is achieved by hydrogen bonds and hydrophobic contacts with the last four LPA2 residues contributing to specific interactions.
LPA1 (zeige LPAR1 Antikörper) and LPA2 are major LPA (zeige APOA Antikörper) receptor subtypes compared with low-expressed LPA3 (zeige LPAR3 Antikörper) in PANC-1 tumor cells.
Pharmacologic activation of LPA2 attenuates Th2-driven allergic airway inflammation in a mouse model of asthma.
These findings identify ATX (zeige ENPP2 Antikörper) and LPA2 as radiation-regulated genes that appear to play a physiological role in DNA repair.
Lysophosphatidic acid gradients induce a spatiotemporally restricted decrease in the mobility of LPA receptor 2 (LPA2) on chemotactic fibroblasts.
Lysophosphatidic acid signals through LPA2 receptors and Galphaq (zeige GNAQ Antikörper) proteins of cultured proximal tubule cells to transactivate latent TGF-beta (zeige TGFB1 Antikörper) in a Rho/Rho-kinase (zeige ROCK2 Antikörper) and alphavbeta6 integrin-dependent manner.
these findings identify LPA acting via lpa2 as a novel negative regulatory pathway that inhibits DC activation and allergic airway inflammation.
LPA(1 (zeige LPAR1 Antikörper)-3) are differentially expressed in the central nervous system and their expression is upregulated in response to injury.
LPA (lysophosphatidic acid) receptors couple to Gq in VSMC (vascular smooth muscle cells)and mediate migration and proliferation which may be mediated through activation of ERK1/2 (zeige MAPK1/3 Antikörper) and Akt (zeige AKT1 Antikörper).
lysophosphatidic acid 2 (zeige PTOV1 Antikörper) receptor mediates down-regulation of Siva-1 (zeige SIVA1 Antikörper) to promote cell survival
A novel in vivo function for LPA signaling as a germ cell survival factor during spermatogenesis.
Enhanced expression of LPA2 Receptor induce a bypass of p19ARF (zeige CDKN2A Antikörper)-p53 (zeige TP53 Antikörper)-dependent senescence.
This gene encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. This protein functions as a lysophosphatidic acid (LPA) receptor and contributes to Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins. An alternative splice variant has been described but its full length sequence has not been determined.
, GHRH receptor
, GRF receptor
, growth hormone-releasing hormone receptor
, pituitary growth hormone releasing hormone receptor
, G protein-coupled receptor
, LPA receptor 2
, LPA receptor EDG4
, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4
, lysophosphatidic acid receptor EDG4
, lysophosphatidic acid receptor Edg-4
, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 4
, pre-B-cell leukemia transcription factor 4